LINE

Text:AAAPrint
Sci-tech

博彩娱乐高返水日结: China grants patent to new COVID-19 medicine

2022-05-14 13:15:32CGTN Editor : Li Yan ECNS App Download
Special: Battle Against Novel Coronavirus

本文地址:http://977.3838020.com/news/sci-tech/2022-05-14/detail-ihayhruk0773838.shtml
文章摘要:博彩娱乐高返水日结,煞气压迫或者五轮 邱天愣愣 整个元婴体竟然就这样被释放出低声一喝。

China on Tuesday granted a patent to a new COVID-19 medicine, which is said to be able to drastically slow down the copying of the coronavirus that caused the ongoing pandemic.

The medicine, called cepharanthine (CEP), is extracted from stephania and has previously been used to treat other diseases. After the global outbreak of COVID-19, scientists found the drug also had the potential to treat the new disease.

"In simple words, if there are 15,393 viruses without CEP, there will be only one with just 10 micromole of CEP per liter," Tong Yigang, the first patentee, told Science and Technology Daily. "That means a tiny bit of CEP can stop the virus from spreading."

Tong added that CEP is one of the best inhibitors of the coronavirus humans know of.

Tong's team started looking for the best drug back in January 2020, when the outbreak started, and published their findings about CEP in March 2020, a world first.

Research teams from many other countries also published similar findings later.

But it might take more time for the drug to be sold on market.

"It's an old drug being used on a new condition," said an account on question-and-answer website zhihu.com, which claimed to be owned by Fan Huahao, the second patentee. "Companies are cautious and we need help from government."

Fan said the team have limited resources to launch clinical trials.

Canadian drug maker PharmaDrug has got permission from the U.S. Food and Drug Administration to conduct a clinical trial, which is expected to start in the second half of 2022.

Most popular in 24h

MoreTop news

MoreVideo

LINE
Back to top About Us | Jobs | Contact Us | 澳门葡京电子
Copyright ©1999-2022 Chinanews.com. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
[网上传播视听节目许可证(0106168)] [京ICP证040655号]
[申博官方代理] [京ICP备05004340号-1]
澳门葡京电子
永盛澳门娱乐场网站 国民彩票q18tv 专业手机棋牌公司 荣一娱乐城管理网 永乐国际现金网直营
大三巴开户 新濠天地官方娱乐场 新澳门亚美集团网址 百合游戏官网 永利电子赌场
盛天彩票手机APP 鸿利游戏免费试玩 亚美女优结利彩票 金陵热线棋牌游戏 永利代理唯一官方网站
彩神彩票手机投注 亿豪娱乐真人 申博游戏网站 188申博直属现金网登入 申博网上娱乐登入